Wegovy, Ask Me Anything—Common Questions Often Heard in the Exam Room, Summarized for You (1)

Are you taking Wegovy injections,

or considering a prescription?

Many patients have

similar questions about Wegovy.

So we prepared this.

The “Wegovy, Ask Me Anything” series!!

Actual Wegovy users

often ask these questions,

and a doctor answers them kindly

from the patient’s perspective.

From basic facts about Wegovy

to lifestyle management,

let’s go through them one by one now.

Q. I sweat a lot after a Wegovy injection. Is that okay?

A. Wegovy is a GLP-1 agonist,

and because it causes metabolic changes in the body,

some patients may experience

increased sweating.

This is one of the common effects

during the body’s adjustment to a new medication.

• In most cases, it is temporary,

and often gradually goes away over time.

• During periods of heavy sweating,

make sure to stay hydrated,

and manage it so that dehydration

or skin irritation from sweating does not occur.

• If sweating is excessive

and seriously interferes with daily life, or if other symptoms (fever, headache, etc.) occur,

please consult a hospital.

Q. On the other hand, I have chills so severe that I need an electric heating mat. Why is that?

A. Chills are a symptom in which the body trembles and feels cold,

and they may occur during the early stage of Wegovy use

due to an antigen-antibody reaction.

If severe, symptoms such as body aches and skin tingling

may appear.

If the chills are mild,

they may be part of the body’s adjustment to the medication,

so there is no need to worry too much.

However, if they continue along with severe chills, fever, and body-ache symptoms,

they may be due to an infection or another adverse reaction,

so you should inform medical staff immediately.

Q. Is it abnormal if my appetite does not decrease even after the injection?

A. Wegovy is a medication that promotes weight loss

by increasing satiety.

However, some users may experience

a situation where their appetite does not decrease,

and this is not uncommon and can be explained by several reasons.

1. Individual differences in drug response

There are individual differences in sensitivity

to GLP-1 receptors.

In particular, depending on factors such as

insulin resistance,

metabolic diseases (diabetes, high blood pressure, fatty liver, etc.),

and the speed of drug metabolism,

the effect of Wegovy can vary.

For some people, appetite suppression appears quickly,

while others only feel the effect after reaching a high dose,

so there are individual differences.

✱Wait a moment here!✱

Q. What is insulin resistance?

A. It refers to a state in which the body’s cells

do not respond adequately to insulin.

In other words, even if insulin is secreted from the pancreas,

cells in the muscles, fat, and liver

do not properly absorb glucose,

causing blood sugar to remain elevated.

2. The gap between expectations and reality

Some patients start with the expectation that

“my appetite will disappear as soon as I get the injection.”

However, the effect of Wegovy appears slowly

and gradually,

and it is important to understand that

the desire for food does not disappear 100%.

Today, we took time to answer questions

that Wegovy users may have

during the early stage of the medication.

Wegovy is an obesity treatment injection

developed by the Danish pharmaceutical company

Novo Nordisk,

and since the U.S. Food and Drug Administration (FDA)

first approved it as a treatment for adult obesity in June 2021,

it has been sequentially approved and used in Europe (January 2022), Korea (April 2023), and other places.

Experiencing various questions or anxieties

during the early stage of use

is completely natural.

By continuously sharing

accurate information based on medical evidence

and clinical experience

related to Wegovy,

we will continue to provide helpful information

to our users.

If you have any questions about Wegovy use,

even something small is fine!

If you have a question, leave it in the comments.

We’ll answer at Bliss!